Article
Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Jun 2009
Agarwal Roshan, Gonzalez-Angulo Ana-Maria, Myhre Simen, Carey Mark, Lee Ju-Seog, Overgaard Jens, Alsner Jan, Stemke-Hale Katherine, Lluch Ana, Neve Richard M, Kuo Wen Lin, Sorlie Therese, Sahin Aysegul, Valero Vicente, Keyomarsi Khandan, Gray Joe W, Borresen-Dale Anne-Lise, Mills Gordon B, Hennessy Bryan T
Abstract excerpt
PURPOSE: We studied the expression levels of cyclins B1, D1, and E1 and the implications of cyclin overexpression for patient outcomes in distinct breast cancer subtypes defined by clinical variables and transcriptional profiling. EXPERIMENTAL DESIGN: The expression levels of cyclins B1, D1, and E1 were quantified in 779 breast tumors and 53 cell lines using reverse phase protein arrays and/or transcriptional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
